Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Diagnostics
MedTech
Grail sees Q3 sales jump, eyes Q1 for FDA Galleri PMA submission
Grail saw a sharp rise in third-quarter sales as it outlined a firmer FDA submission date for its Galleri cancer blood test.
Ben Adams
Nov 13, 2025 9:05am
Promega wins FDA OK as Keytruda-Lenvima companion diagnostic
Nov 13, 2025 4:00am
Guardant blood test gives early warning of cancer progression
Nov 10, 2025 8:15am
Medtech vet takes helm at AI head injury company BrainScope
Nov 4, 2025 1:15pm
LabCorp's diagnostics shine in Q3, but revenue forecast dims
Oct 28, 2025 10:15am
China pricing pressure weighs on Roche's diagnostics business
Oct 23, 2025 8:40am
